Cancer is the second leading cause of death in the United States behind only heart disease. More than 500,000 people died of the disease last year, accounting for 1 in 4 deaths. Moreover, the disease is enormously taxing on our healthcare system, with more than $260M spent each year on cancer treatments. While there are a variety of treatment options available, none are curative.

Our work is focused on identifying new breakthrough approaches for treating the disease. Because each cancer is unique and there are variants even within the same subtype, we are exploring novel approaches including personalized medicine to dramatically improve the quality of care for cancer patients. To find out more about our work in this area, contact us.